Results 221 to 230 of about 34,325,732 (253)

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

open access: yesPhytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko   +3 more
wiley   +1 more source

Therapeutic Potential of Linalool in Endometriosis: Modulation of Oxidative Stress, Inflammation, and Apoptosis in a Rat Model. [PDF]

open access: yesFASEB J
Tadayonfar R   +7 more
europepmc   +1 more source

HBV HBx protein masks epigenetic reader Spindlin1 via an inter-molecular zinc finger to subvert transcriptional control. [PDF]

open access: yesNat Commun
Clavier A   +8 more
europepmc   +1 more source

Helping Apo2L/TRAIL in the Battle: Synergistic Therapeutic Approaches for Cancer Therapies. [PDF]

open access: yesInt J Mol Sci
Fuior EV   +15 more
europepmc   +1 more source

Programmed cell death in metabolic syndrome: From molecular mechanisms to therapeutic strategies (Review). [PDF]

open access: yesInt J Mol Med
Zhong J   +8 more
europepmc   +1 more source

BCL-2 family proteins form distinct functional interaction networks when primed with full-length BAD compared with the BAD-like mimetic ABT-737

open access: yes
Gilmore A   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11

Journal of Drug Targeting, 2021
Histone deacetylases (HDACs) have been revealed to be involved in cerebrovascular diseases, while the role of HDAC9 in intracranial aneurysm (IA) remains seldom studied. We aim to explore the role of the HDAC9/microRNA-92a (miR-92a)/Bcl-2-like protein 11 (BCL2L11) axis in IA progression.Expression of HDAC9, miR-92a and BCL2L11 in IA tissues was ...
Qilin Qin, Wenjia Ma
exaly   +3 more sources

miR-556-3p/Disabled Homolog 2-Interacting Protein (dab2ip) Promotes Cancer Progression by Down-Regulating Bcl-2-Like Protein 11 (BIM) Expression in Colorectal Cancer

Journal of Biomaterials and Tissue Engineering, 2022
Colorectal cancer (CRC) is a major threat affecting human health. Studies have shown that miR-556-3p can regulate dab2ip and promote tumor deterioration, and up-regulation of BIM inhibits CRC cell progression. However, the interaction between miR-556-3p/dab2ip and BIM in CRC is unknown.
Jiaqi Liu   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy